Target Name: FKBP10
NCBI ID: G60681
Other Name(s): OI6 | FK506 binding protein 10 | immunophilin FKBP65 | PPIase FKBP10 | FK506 binding protein 10 (65 kDa) | Rotamase | 65 kDa FK506-binding protein | FK506-binding protein 10 | rotamase | hFKBP65 | FK506 binding protein 10, 65 kDa | BRKS1 | Peptidyl-prolyl cis-trans isomerase FKBP10 | OI11 | FKB10_HUMAN | Immunophilin FKBP65 | Cytonectin | FKBP-65 | FKBP65 | FKBP-10 | FLJ22041 | 65 kDa FKBP | FKBP prolyl isomerase 10 | PPIASE

FKBP10: A Drug Target and Biomarker for the Treatment of Inflammatory Diseases

Introduction

Inflammatory diseases, such as rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD), affect millions of people worldwide and cause significant morbidity and mortality. The immune system's response to inflammation is often overwhelmed, leading to chronic inflammation that can cause damage to the body's tissues and organs. The search for new treatments and drug targets has become one of the hot spots in current research. In recent years, with the deepening of the understanding of inflammatory diseases, some new biomarkers and drug targets have been discovered. FKBP10, the full name of fluoroalkanedioic acid binding protein 10, is a coding gene that plays an important role in inflammatory responses. This article will introduce the research progress of FKBP10 as a drug target (or biomarker) in the treatment of inflammatory diseases.

Discovery and role of FKBP10

FKBP10 is a coding gene that belongs to the FKBP family. The FKBP family is a class of transcription factors that are mainly involved in intracellular signal transduction processes. FKBP10 is a member of this family and is mainly involved in intracellular signal transduction and metabolic processes. FKBP10 plays an important role in the inflammatory response and is a key molecule in the inflammatory response.

Research shows that FKBP10 plays an important role in inflammatory diseases. For example, activation of FKBP10 can lead to a series of signal transduction pathways in cells, including NF-kappa-B, PI3K, MAPK, etc. These signal transduction pathways play a key role in the inflammatory response and can lead to the symptoms and pathological changes of inflammatory diseases. In addition, activation of FKBP10 can also lead to a series of metabolic changes in cells, such as glycolysis, fatty acid synthesis, etc. These metabolic changes also play an important role in the inflammatory response.

as a drug target

Because FKBP10 plays an important role in inflammatory responses, it has emerged as a potential drug target. Researchers are exploring FKBP10 as a drug target to treat inflammatory diseases. Currently, several studies are evaluating the effectiveness and safety of FKBP10 as a drug target for the treatment of inflammatory diseases.

First, researchers are exploring FKBP10 as a treatment for rheumatoid arthritis (R

Protein Name: FKBP Prolyl Isomerase 10

Functions: PPIases accelerate the folding of proteins during protein synthesis

More Common Targets

FKBP11 | FKBP14 | FKBP15 | FKBP1A | FKBP1A-SDCBP2 | FKBP1B | FKBP1C | FKBP2 | FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A